(rivaroxaban)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 06/06/2024
Please refer to the following sections of the enclosed Full Prescribing Information that are relevant to your inquiry: DESCRIPTION.
XARELTO tablets, granules for oral suspension and their excipients do not contain wheat, rye, barley, oats, spelt, or kamut. XARELTO excipients do not contain gluten as an ingredient.1-
Mannitol, an inactive ingredient in the granules for oral suspension, can be derived from wheat. Wheat gluten content is < 20 mg/kg.3
Since XARELTO tablets, granules for oral suspension, and their excipients are not tested for gluten, the possibility of cross-contamination with gluten during the manufacturing process of the individual ingredients cannot be eliminated.1,3
1 | Data on File. Patient Safety and Compliance Information (EXC and IMC)-Xarelto 10 mg. Janssen Scientific Affairs, LLC.; 2022. |
2 | |
3 | |
4 |